Fosbretabulin: Phase II/III started

Mateon began the double-blind, placebo-controlled, U.S. Phase II/III FOCUS trial to evaluate

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE